Explore the latest approaches to pharmaceutical microbiological testing, including rapid PCR-based mycoplasma detection, method validation and integration into contamination control strategies.
As pharmaceutical manufacturers seek faster, more actionable microbiological data, rapid microbiological methods (RMMs) offer new opportunities to support quality control and contamination monitoring.
But moving beyond conventional testing involves more than adopting faster technologies. Assay sensitivity, sample preparation, validation requirements and integration into existing workflows all influence successful implementation.
This Microbiology & RMM In-Depth Focus brings together expert perspectives on the technologies, challenges and considerations shaping pharmaceutical microbiological quality control.
What you’ll discover
- Accelerate mycoplasma detection: Explore how rapid PCR-based methods can reduce testing timelines from weeks to hours and support more timely quality decisions.
- Navigate RMM validation challenges: Examine how assay sensitivity, specificity, sample preparation and matrix effects influence method performance.
- Strengthen contamination control strategies: Understand why rapid detection must be supported by robust sampling, monitoring and contamination control practices
- Evaluate the practical limitations of PCR: Explore challenges including residual DNA detection, interpretation of positive results and distinguishing viable from non-viable microorganisms.
- Support implementation in regulated environments: Gain insight into integrating rapid testing technologies within pharmaceutical manufacturing and QC workflows.
Expert insights for pharmaceutical quality professionals
Featuring perspectives from Charles River, LabVantage, Microbiologics and academic researchers, this In-Depth Focus examines developments in pharmaceutical microbiological testing.
Download your copy to explore the technologies and considerations informing faster, more effective microbiological quality control.
Download Now




No comments yet